American Bio Medica Supplying Drug Tests to Cabela's(R)
KINDERHOOK, N.Y. -- (BUSINESS WIRE) -- June 13, 2006 -- American Bio Medica Corporation (NASDAQ:ABMC) today announced that they are supplying Cabela's Incorporated (NYSE:CAB) with their point of collection drug screening kits. The drug screens will be used at Cabela's retail outlets for pre-employment and random drug screening of its employees.
Cabela's currently has 14 retail locations across the United States and has recently announced that throughout 2007 and into 2008 they plan to open stores in another 13 locations in the United States. As of January 2006, Cabela's employed approximately 9,800 employees nationwide.
ABMC Chief Executive Officer Stan Cipkowski stated, "ABMC prides itself on supplying cost effective quality drug screening devices and superior service to our customers and we are pleased that Cabela's has chosen ABMC to be its provider of drug screening devices for use in its drug free workplace program."
For more information on American Bio Medica Corporation or its products, please visit www.abmc.com.
About American Bio Medica Corporation
American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets accurate, cost-effective immunoassay diagnostic test kits, including some of the world's most effective point of collection tests for drugs of abuse. The Company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets. ABMC's Rapid Drug Screen(R), Rapid One(R), Rapid TEC(R), RDS(R) InCup(R) and Rapid TOX(TM) products test for the presence or absence of drugs of abuse in urine, while OralStat(R) tests for the presence or absence of drugs of abuse in oral fluids. ABMC's Rapid Reader(TM) is a compact, portable device that, when connected to any computer, interprets the results of an ABMC drug screen, and sends the results to a data management system, enabling the test administrator to easily manage their drug testing program.
About Cabela's Incorporated
Cabela's Incorporated, headquartered in Sidney, Nebraska, is the world's largest direct marketer, and a leading specialty retailer, of hunting, fishing, camping and related outdoor merchandise. Since the Company's founding in 1961, Cabela's has grown to become one of the most well-known outdoor recreation brands in the world, and has long been recognized as the World's Foremost Outfitter(R). Through Cabela's well-established direct business and its growing number of destination retail stores, it offers a wide and distinctive selection of high-quality outdoor products at competitive prices while providing superior customer service. Cabela's also issues the Cabela's Club(R) VISA credit card, which serves as its primary customer loyalty rewards program.
This release may contain forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results to differ, and such differences could be material. Such risks and uncertainties include, but are not limited to, the following: continued acceptance of the Company's products, increased levels of competition in our industry, the acceptance of new products, inherent risks associated with product development and intellectual property rights, the Company's dependence on key personnel, third party sales and suppliers. There can be no assurance that the Company will be successful in addressing such risks and uncertainties and the Company assumes no duty to update any forward-looking statements based upon actual results. Investors are strongly encouraged to review the section entitled "Risk Factors" in the Company's annual report on Form 10-KSB for the fiscal year ended December 31, 2005, and quarterly reports on Form 10-QSB on file with the Securities and Exchange Commission for a discussion of risks and uncertainties that could affect operating results and the market price of the Company's common shares.
CONTACT: American Bio Medica Corporation Stan Cipkowski, 800-227-1243, Ext 106 or BPC Financial Marketing John Baldissera, 800-368-1217 SOURCE: American Bio Medica Corporation